New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
08:38 EDTCSIICardiovascular Systems discloses Civil Investigative Demand
Cardiovascular Systems disclosed late Friday that it received a letter from the U.S. Attorney's Office for the Western District of North Carolina stating that it is investigating the company to determine whether it has violated the False Claims Act, resulting in the submission of false claims to federal and state health care programs, including Medicare and Medicaid. The letter enclosed a Civil Investigative Demand for written interrogatories and document requests. Cardiovascular said, "The Company maintains rigorous policies and procedures to promote compliance with the False Claims Act and other regulatory requirements, and is working with the U.S. Attorney’s Office to promptly respond to the CID. However, the Company cannot predict when the investigation will be resolved, the outcome of this investigation or its potential impact on the Company."
News For CSII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
07:43 EDTCSIICMS panel removes Cardiovascular Systems overhang, says Leerink
Leerink analyst Danielle Antalffy says the CMS Medicare Evidence Development & Coverage Advisory Committee panel on peripheral arterial disease removes a near-term overhang on shares of Cardiovascular Systems. The company should return to 20%-plus growth with both outpatient reimbursement and CMS panel risk now addressed, Antalffy tells investors in a research note. She keeps an Outperform rating on the stock with a $45 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use